Evidence map›Paper›PMID 22294688›Full record

ArticleThe Journal of biological chemistry2012

G-protein-coupled receptor kinase interactor-1 (GIT1) is a new endothelial nitric-oxide synthase (eNOS) interactor with functional effects on vascular homeostasis.

Songling Liu, Richard T Premont, Don C Rockey

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Subcellular Localization Guides eNOS Function.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. β-Arrestin2 is a critical component of the GPCR-eNOS signalosome.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  9. Article
  10. Article
  11. Biology of portal hypertension.Hepatology international · 2018
    Review
  12. Review
  13. Article
  14. Article
  15. The Molecular Basis of Portal Hypertension.Transactions of the American Clinical and Climatological Association · 2017
    Review
  16. Review
  17. Article
  18. The eNOS signalosome and its link to endothelial dysfunction.Pflugers Archiv : European journal of physiology · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Songling LiuUniversity of Texas Southwestern Medical Center, Division of Digestive and Liver Diseases, Dallas, Texas 75390, USA.
Richard T Premont
Don C Rockey
The University of Texas Southwestern Medical Center · USDuke University Hospital · US

Funding

NO AND THE CELLULAR PATHOGENESIS OF PORTAL HYPERTENSIONR01DK057830 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI ROCKEY, DON C. · 2000 to 2012
$2.6M
NIDDK NIH HHS R01 DK057830NIDDK NIH HHS R01 DK 57830
6 · The paper itself

Abstract

Endothelial cell nitric-oxide (NO) synthase (eNOS), the enzyme responsible for synthesis of NO in the vasculature, undergoes extensive post-translational modifications that modulate its activity. Here we have identified a novel eNOS interactor, G-protein-coupled receptor (GPCR) kinase interactor-1 (GIT1), which plays an unexpected role in GPCR stimulated NO signaling. GIT1 interacted with eNOS in the endothelial cell cytoplasm, and this robust association was associated with stimulatory eNOS phosphorylation (Ser(1177)), enzyme activation, and NO synthesis. GIT1 knockdown had the opposite effect. Additionally, GIT1 expression was reduced in sinusoidal endothelial cells after liver injury, consistent with previously described endothelial dysfunction in this disease. Re-expression of GIT1 after liver injury rescued the endothelial phenotype. These data emphasize the role of GPCR signaling partners in eNOS function and have fundamental implications for vascular disorders involving dysregulated eNOS.

Indexed as

HomeostasisAnimalsCell Cycle ProteinsCells, CulturedDown-RegulationEndothelial CellsEndothelin-1Gene ExpressionHepatic VeinsHypertension, PortalLiverMaleNitric OxideNitric Oxide Synthase Type IIIPhosphoproteinsProtein BindingCell Cycle ProteinsEndothelin-1Git1 protein, ratNitric OxideNitric Oxide Synthase Type IIINos3 protein, ratPhosphoproteinsProto-Oncogene Proteins c-aktReceptor, Endothelin B

Identifiers

PMID22294688
PMCPMC3320980
OpenAlexW2159823730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.